BEAT-PCD will be running a half day session on Primary Ciliary Dyskinesia at the 7th World Bronchiectasis Conference 2024. Along with the organizing committee, we invite you to join and contribute to the World Bronchiectasis Community meeting planned in Dundee from 4 to 6 July 2024. Register and Submit an abstract here
Welcome letter from James D. Chalmers, Chairman of the 7th WBC
Dear Colleagues & Friends,
It’s a great pleasure –as Chairperson of the 7thWorld Bronchiectasis Conference 2024 -to invite you to join and contribute to the World Bronchiectasis Community meeting planned in Dundee from 4 to 6 July 2024.
The last years have been amazing for our international community.
Bronchiectasis has emerged from its history as a neglected condition to now being a dynamic field experiencing rapid progress. New translational science ishelping to revealthe physiopathologicalmechanismsbehind the disease and identify new targets. EMBARC and National Registries have contributed to describing the epidemiology, providing us with precious insights into the natural history of the disease, its comorbidities,and its current management approachesacross different countries. Together we have set key priorities forresearchto improve the quality of life of patients.
The COVID-19 pandemic and the past several years of scientific progress have clearly placed respiratory tract infections at the centre of public health, clinical practice, and scientific debate, helping us to provide new instruments to prevent andtreat exacerbations and comorbidities.
Our Multidisciplinaryteams, including specialist nurses, physiotherapists and other healthcare professionals are improvingthe patient journey, in some countries where resources are being devoted to bronchiectasis, while in many countries we still have a long way to go to succeed in being included in the delivery of healthcare for bronchiectasis patients.
After years of repurposing therapies from COPD and cystic fibrosis, new therapies are in development specifically for bronchiectasis and therapeutic breakthroughs feel closer than ever. The omics revolution is now helping us in starting to breakthrough the heterogeneity of the disease as well as to understand the causesbehind the symptoms.
Bronchiectasis stands on the threshold of a new age of exciting science and therapeutic development.
With this exciting context, I invite you to participate and contribute to the next World Bronchiectasis Conference and work together with us to create a better future for our patients with bronchiectasis.
Yours Sincerely,
James D. Chalmers
